focus -WSS

focus

author：comprehensive 2025-10-02 13:40:44 - browse：99

Photo illustration of Chris Viehbacher -- biotech coverage from STAT — Chris Viehbacher took over as Biogen CEO in November. Suzanne Kreiter/Globe staff; Photo illustration Alex Hogan/STAT

This was supposed to be the new Biogen. When Chris Viehbacher, a respected pharmaceutical executive, took over as CEO in November, Wall Street saw him as a steadying force for the wayward company and a strong personality who would stand up to its quarrelsome board.

Instead, Biogen’s board has saddled Viehbacher with the first crisis of his tenure at the company. Alex Denner, a long-time director, nominated a biotech executive who is also the mother of his child to succeed him on the board, and Biogen chose not to disclose the couple’s relationship to shareholders, an omission that shocked people close to the company and undermined the notion that Biogen was changing for the better.

“It’s just disappointing to see after all the criticism that has been levied at the company over the last few years, there really seems to be no self-awareness going into this recommendation,” said Brian Skorney, a securities analyst at Baird who covers Biogen.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Patients, digital health players weigh in on FTC's data privacy plan

entertainment

WSS

Bird flu researchers hone in on Finland’s mink farms

Senators push IRS to launch nonprofit hospital probe

Bird flu researchers hone in on Finland’s mink farms

Lilly's Alzheimer's drug donanemab backed by FDA advisers

Illumina slashes 2023 revenue projections yet again

Timeline: How the deadly wildfires took over Maui day by day

leisure time

focus

focus

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

The system is set up to fail children with medical complexity

In age of alternative facts, a scholarly course on calling out crap

Indictment alleges Trump's ex

Apple is now the first public company to be valued at $3 trillion

Stephen Quake on the Chan Zuckerberg quest to conquer disease

Cancer drug shortages should be causing more outrage

Montana youths win climate lawsuit against state for promoting fossil fuels

Medicare details structure of new drug price negotiation program

Novo Nordisk touts Wegovy study, but still struggling with supply

explore

Study: Why relieving medical debt did not improve financial outcomes

Moderna says combo Covid

Teladoc has a new CEO, but challenges remain the same

Be careful with at

Deposition: Sackler embraced plan to conceal OxyContin’s strength

Dozens dead from Maui wildfires: What we know about the victims

entertainment

entertainment

Wikipedia

hotspot